| Literature DB >> 23538392 |
Ólöf Birna Kristjánsdóttir1, Egil A Fors, Erlend Eide, Arnstein Finset, Tonje Lauritzen Stensrud, Sandra van Dulmen, Sigrid Hørven Wigers, Hilde Eide.
Abstract
BACKGROUND: Internet-based interventions are increasingly used to support self-management of individuals with chronic illnesses. Web-based interventions may also be effective in enhancing self-management for individuals with chronic pain, but little is known about long-term effects. Research on Web-based interventions to support self-management following participation in pain management programs is limited.Entities:
Mesh:
Year: 2013 PMID: 23538392 PMCID: PMC3636011 DOI: 10.2196/jmir.2442
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Study flow chart.
Figure 2The smartphone's screen showing a diary in Norwegian.
Figure 3The smartphone's screen showing feedback in Norwegian.
Characteristics at admission to the inpatient rehabilitation center.
| Characteristic | Smartphone intervention (n=69)a | Control (n=66)a | |
| Age, mean (SD), n | 44.59 (11.13), 69 | 43.80 (11.20), 65 | |
|
|
|
|
|
|
| Married or cohabiting | 60.9% (n=42) | 68.2% (n=45) |
| Divorced | 13.0% (n=9) | 9.1% (n=6) | |
| Single | 18.8% (n=13) | 15.2% (n=10) | |
| Widow | 5.8% (n=4) | 3.0% (n=2) | |
| Unknown | 1.4% (n=1) | 4.5% (n=3) | |
|
|
|
|
|
|
| ≤ 10 years (elementary) | 18.8% (n=13) | 12.1% (n=8) |
| 11-13 years (high school) | 27.5% (n=19) | 45.5% (n=30) | |
| >13 years (College/University) | 43.5% (n=30) | 34.8% (n=23) | |
| Unknown | 10.1% (n=7) | 7.6% (n=5) | |
|
|
|
|
|
|
| Working/studying | 21.7% (n=15) | 12.1% (n=8) |
| Unemployed | 4.3% (n=3) | 1.5% (n=1) | |
| On sick leave | 39.1% (n=27) | 51.5% (n=34) | |
| On disability pension | 17.4% (n=12) | 19.7% (n=13) | |
| Part time working/studying and part time sick leave | 11.6% (n=8) | 7.6% (n=5) | |
| Other combination of the above | 5.8% (n=4) | 6.1% (n=4) | |
| Unknown | 0% | 1.5% (n=1) | |
| Diagnosed with fibromyalgia (valid %) | 80.9% (n=55) | 84.4% (n=54) | |
| Duration of symptoms (years), mean (SD), n | 13.11 (8.78) | 15.47 (12.09) | |
| PCSb, mean (SD), n | 21.24 (10.33), 63 | 20.80 (9.45), 62 | |
| CPAQb, mean (SD), n | 56.48 (15.02), 58 | 53.87 (13.81), 57 | |
| FIQb, mean (SD), n | 58.75 (16.39), 69 | 58.58 (16.04), 66 | |
| SF-8, physicalb; mean (SD), n | 31.91 (7.57), 65 | 34.75 (7.35), 62 | |
| SF-8, mentalb, mean (SD), n | 39.33 (10.49), 65 | 39.34 (9.61), 62 | |
| GHQ-12b, mean (SD), n | 3.32 (3.38), 62 | 3.02 (3.38), 61 | |
| CPVIb, mean (SD), n | 2.07 (0.95), 64 | 2.01 (0.73), 61 | |
|
|
|
| |
|
| Pain, mean (SD), n | 67.08 (17.47), 69 | 57.85 (21.60), 66 |
| Fatigue, mean (SD), n | 67.40 (23.73), 69 | 64.72 (21.02), 66 | |
| Sleep disturbance, mean (SD), n | 57.24 (26.22), 68 | 55.16 (23.38), 66 | |
|
| Depression, mean (SD), n | 34.73 (29.15), 68 | 32.93 (29.26), 65 |
a Patients meeting exclusion criteria after randomization were not included in this analysis.
b VAS, visual analogue scale (0-100c); PCS, Pain Catastrophizing Scale (score range 0-52c); CPAQ, Chronic Pain Acceptance Questionnaire (score range 0c-120); FIQ, Fibromyalgia Impact Questionnaire (0-100c); SF-8 (0c-100), Short Form; GHQ-12, questions from the General Health Questionnaire (score range 0-12c); CPVI, Chronic Pain Values Inventory (success score, range 0c-6).
c Values that indicate maximum symptom scores/least health.
Means and standard deviations for the primary outcome at admission to the inpatient rehabilitation (T1), at discharge (T2), and 11 months (T5) after the intervention period.
| Primary outcome measure, | Group | T1a
| T2a, b
| T5a
|
|
|
|
|
|
|
|
| Intervention | 21.24 (10.33), 63 | 15.12 (9.61), 63 | 11.50 (8.68), 44 |
|
| Control | 20.80 (9.45), 62 | 15.41 (9.62), 59 | 14.73 (9.95), 43 |
|
|
|
|
|
|
|
| Intervention | 21.24 (10.33), 63 | 16.06 (10.37), 68 | 13.72 (10.02), 69 |
|
| Control | 20.80 (9.45), 62 | 15.33 (9.31), 65 | 15.57 (10.40), 66 |
|
|
|
|
|
|
|
| Intervention |
|
| 12.80, 69 |
|
| Control |
|
| 14.74, 66 |
|
|
|
|
|
|
|
| Intervention | 20.56 (10.08), 43 | 14.61 (8.93), 45 | 11.92 (8.97), 39 |
|
| Control | 20.78 (9.59), 60 | 15.46 (9.76), 57 | 14.73 (9.95), 43 |
|
|
|
|
|
|
|
| Intervention |
|
| 12.25, 48 |
|
| Control |
|
| 14.66, 64 |
|
|
|
|
|
|
|
| Intervention | 30.2%, 13 | 15.6%, 7 | 12.8%, 5 |
|
| Control | 33.3%, 20 | 17.5%, 10 | 18.6%, 8 |
a T1, at admission to the inpatient program; T2, at discharge from the inpatient program; T5, 11-month follow-up
b No differences between groups at T2 (all P values >.05).
Within-group differences and effect sizes (ES) for the primary outcome.
| Primary outcome, PCS | Mean | 95% CI | ES for T2-T5 |
| Mean | 95% CI | ES for T1-T5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -2.60 (8.72), 42 | -5.32, .11 | .29 | .06 | -7.36 (7.87), 39 | -9.91, -4.81 | .80 | < .001 |
|
| Control | -.21 (7.32), 40 | -2.55, 2.13 | .02 | .86 | -5.30 (7.30), 41 | -7.60, -2.99 | .56 | < .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -2.36 (8.41), 68 | -4.39, -.32 | .23 | .02 | -7.57 (8.23), 63 | -9.64, -5.50 | .76 | < .001 |
|
| Control | .40 (7.20), 65 | -1.39, 2.18 | -.04 | .66 | -4.65 (7.43), 62 | -6.54, -2.76 | .47 | < .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -2.61, 63 | -5.33, .10 |
| .06 | -8.22, 63 | -10.86, -5.57 |
| < .001 |
|
| Control | -.15, 59 | -2.75, 2.46 |
| .91 | -5.79, 62 | -8.12, -3.46 |
| < .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -3.04 (8.74), 37 | -5.95, -.12 | 0.33 | .04 | -7.23 (8.01), 34 | -10.03, -4.44 | .77 | < .001 |
|
| Control | -.21 (7.32), 40 | -2.55, 2.13 | 0.02 | .86 | -5.30 (7.30), 41 | -7.60, -2.99 | .56 | < .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -2.45, 45 | -5.29, .38 |
| .09 | -7.93, 43 | -10.72, -5.14 |
| < .001 |
|
| Control | -.27, 57 | -2.84, 2.30 |
| .84 | -5.85,60 | -8.15, -3.54 |
| < .001 |
a T1, at admission to the inpatient program; T2, at discharge from the inpatient program; T5, 11-month follow-up.
b P values for paired samples t-tests.
Means and standard deviations for the secondary outcomes at admission to the inpatient rehabilitation (T1), at discharge (T2), and 11 months (T5) after the intervention period, for the completers.
| Secondary outcome measures | Group | T1a
| T2a,b
| T5a
|
|
|
|
|
|
|
|
| Intervention | 56.45 (15.22), 40 | 62.00 (13.62), 44 | 71.62 (14.11), 39 |
|
| Control | 53.94 (13.92), 56 | 62.21 (10.15), 57 | 67.05 (15.18), 42 |
|
|
|
|
|
|
|
| Intervention | 58.46 (17.26), 48 | 46.38 (16.92), 47 | 49.24 (21.34), 38 |
|
| Control | 58.35 (16.18), 64 | 49.10 (17.32), 62 | 53.75 (17.73), 45 |
|
|
|
|
|
|
|
| Intervention | 32.12 (7.74), 45 | 36.68 (8.42), 40 | 34.38 (9.88), 39 |
|
| Control | 34.98 (7.13), 60 | 35.86 (8.24), 49 | 37.35 (7.65), 44 |
|
|
|
|
|
|
|
| Intervention | 39.50 (10.67), 45 | 45.70 (8.06), 40 | 45.50 (10.70), 39 |
|
| Control | 39.09 (9.61), 60 | 44.83 (9.69), 49 | 43.87 (9.09), 43 |
|
|
|
|
|
|
|
| Intervention | 3.19 (3.21), 43 | 1.20 (2.02), 45 | 1.95 (2.64), 38 |
|
| Control | 2.97 (3.43), 59 | 0.63 (1.01), 57 | 2.20 (2.82), 44 |
|
|
|
|
|
|
|
| Intervention | 2.05 (0.95), 44 | 2.47 (0.91), 46 | 2.78 (1.00), 39 |
|
| Control | 2.02 (0.74), 59 | 2.52 (0.68), 54 | 2.50 (0.77), 43 |
|
|
|
|
|
|
|
| Intervention | 66.59 (17.58), 48 | 53.07 (22.20), 47 | 56.28 (28.24), 38 |
|
| Control | 57.32 (21.56), 64 | 52.99 (21.27), 61 | 55.85 (22.73), 45 |
|
|
|
|
|
|
|
| Intervention | 69.29 (23.98), 48 | 51.38 (27.75), 47 | 60.79 (28.56), 38 |
|
| Control | 64.08 (21.01), 64 | 50.10 (24.28), 61 | 61.63 (23.63), 45 |
|
|
|
|
|
|
|
| Intervention | 54.77 (26.99), 47 | 43.97 (25.77), 47 | 51.68 (30.45), 38 |
|
| Control | 54.59 (23.31), 64 | 48.12 (24.57), 62 | 53.08 (25.95), 45 |
|
|
|
|
|
|
|
| Intervention | 30.68 (28.71), 47 | 19.84 (24.08), 47 | 22.82 (25.89), 38 |
|
| Control | 32.65 (29.29), 63 | 27.36 (28.51), 61 | 28.93 (27.71),45 |
a T1, at admission to the inpatient program; T2, at discharge from the inpatient program; T5, 11-month follow-up.
b No differences between groups at T2 (all P values >.05; GHQ and depression (VAS), P=.08).
Mean differences for the secondary outcomes within-groups, confidence intervals (CI) and effect sizes (ES) for the completers.
| Secondary outcome measures |
| Mean | 95% CI T2-T5a | ES for T2-T5a |
| Mean | 95% CI T1-T5a | ESa for T1-T5 |
|
|
|
|
|
| ||||||
|
| Intervention | 10.20 (9.57), 35 | 6.91, 13.49 | .73 | <.001 | 14.12 (12.46), 33 | 9.70, 18.54 | .95 | < .001 |
|
| Control | 2.15 (10.77), 39 | -1.34, 5.64 | .17 | .22 | 8.45 (14.00), 38 | 3.85, 13.05 | .62 | .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | 1.40 (21.15), 37 | -5.65, 8.45 | -.08 | .69 | -8.15 (21.95), 38 | -15.36, -.93 | .42 | .03 |
|
| Control | 7.05 (17.24), 44 | 1.81, 12.29 | -.40 | .01 | -2.27 (16.23), 45 | -7.15, 2.60 | .13 | .35 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | -3.20 (8.84), 33 | -6.33, -.06 | -.36 | .046 | 1.11 (8.99), 36 | -1.93, 4.15 | .12 | .46 |
|
| Control | .54 (8.18), 34 | -2.32, 3.39 | .06 | .71 | 1.01 (6.99), 42 | -1.17, 3.19 | .14 | .36 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | .39 (10.09), 33 | -3.19, 3.97 | .04 | .82 | 6.45 (11.71), 36 | 2.49, 10.42 | .58 | .002 |
|
| Control | -1.61 (11.53), 33 | -5.70, 2.48 | -.17 | .43 | 3.10 (6.99), 42 | .93, 5.28 | .36 | .006 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | .69 (3.06), 35 | -.36, 1.74 | -.28 | .19 | -1.12 (4.07), 34 | -2.54, .30 | .36 | .12 |
|
| Control | 1.68 (2.94), 40 | .74, 2.61 | -.85 | .001 | -.61, 3.39, 41 | -1.68, .46 | .20 | .26 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | .29 (.90), 37 | -.01, .59 | .30 | .06 | .56 (.72), 35 | .32, .81 | .59 | < .001 |
|
| Control | -.11 (.88), 36 | -.41, .19 | -.16 | .46 | .40 (.61), 41 | .21, .59 | .54 | < .001 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | 1.43 (32.58), 37 | -9.44, 12.29 | -.06 | .79 | -9.86 (25.54), 38 | -18.25, -1.46 | .43 | .02 |
|
| Control | 5.53 (20.73), 43 | -.85, 11.91 | -.25 | .09 | -1.82 (23.65), 45 | -8.92, 5.28 | .08 | .61 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | 8.71 (33.56), 37 | -2.48, 19.90 | -.32 | .12 | -8.94 (31.93), 38 | -19.43, 1.56 | .36 | .09 |
|
| Control | 14.96 (24.50), 43 | 7.42, 22.49 | -.61 | <.001 | -.93 (22.65), 45 | -7.73, 5.87 | .04 | .78 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | 5.55 (33.26), 37 | -5.54, 16.64 | -.20 | .32 | -2.29 (33.46), 37 | -13.45, 8.86 | .08 | .68 |
|
| Control | 7.43 (27.09), 44 | -.81, 15.66 | -.28 | .08 | .45 (30.11), 45 | -8.59, 9.50 | -.02 | .92 |
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention | 1.11 (28.71), 37 | -8.46, 10.68 | -.05 | .82 | -8.13 (27.78), 37 | -17.40,1.13 | .29 | .08 |
|
| Control | 7.27 (27.43), 43 | -1.18, 15.71 | -.26 | .09 | .99 (23.13), 45 | -5.96, 7.94 | -.04 | .78 |
aT1, at admission to the inpatient program; T2, at discharge from the inpatient program; T5, 11-month follow-up.
b P values for paired samples t-tests.